Kiran Nistala

CIK: 0002003539

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ZURA

Zura Bio Ltd

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ZURA
Zura Bio Ltd
Apr 1, 2026
Award(A)
Employee Share Option (Right to Buy)
Direct
340.9K shares-
ZURA
Zura Bio Ltd
Feb 27, 2025
Award(A)
Employee Share Option (Right to Buy)
Direct
341.7K shares-
ZURA
Zura Bio Ltd
Apr 22, 2024
Award(A)
Direct
3.2K shares at avg. $3.13$10K

		Type	Shares	Price		Ownership
Apr 1, 2026	ZURA Zura Bio Ltd	Award(A) Employee Share Option (Right to Buy)	340,900	-	-	Direct
Feb 27, 2025	ZURA Zura Bio Ltd	Award(A) Employee Share Option (Right to Buy)	341,700	-	-	Direct
Apr 22, 2024	ZURA Zura Bio Ltd	Award(A)	3,195	$3.13	$10,000	Direct

1-3 of 3 transactions

About Nistala Kiran

Nistala Kiran (SEC CIK 0002003539) files insider reports with the SEC as Officer of Zura Bio Ltd (ZURA).

Signal8 holds 3 ownership filings by Nistala Kiran, all Form 4s, filed between Sep 9, 2024 and Apr 2, 2026. Those filings report 3 transactions, from Apr 22, 2024 to Apr 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nistala Kiran's filings is in HENDERSON, NV.

Recent filings by Nistala Kiran

Apr 1, 2026: Grant or award of ZURA derivative securities (Form 4, code A).
Feb 27, 2025: Grant or award of ZURA derivative securities (Form 4, code A).
Apr 22, 2024: Grant or award of ZURA shares (Form 4, code A).

Other insiders filing for Zura Bio Ltd (ZURA)

Mathew Marlyn Teresa, VP, Principal Acctg. Officer
Jarrett Jennifer, Director
Thiara Parvinder, Director
Schoch Steven J, Director
Nirula Ajay, Director
Munshi Amit, Director

How to read Form 4 transaction codes